SAN FRANCISCO--(BUSINESS WIRE)--TransMedics, Inc., an emerging medical technology company developing advanced solutions for better, more effective organ transplants, announced today the results from the European PROTECT I trial demonstrating the successful use of the Organ Care System™ (OCS) in maintaining and transporting donated hearts for transplant surgery. These data were presented at the International Society for Heart and Lung Transplantation's (ISHLT) 27th Annual Meeting & Scientific Session in San Francisco.
